본문 바로가기
KERD
논문KCI 등재

경도인지장애, 알쯔하이머병에서 혈장 Homocysteine, Folate, Vitamin B12 농도와 인지기능

Serum Levels of Homocysteine, Folate, and Vitamin B12 and Cognitive Function in Mild Cognitive Impairment and Alzheimer’s Disease

2

조회

0

다운로드

0

인용

0

참고문헌

초록

Objectives:This study aimed to investigate the serum levels of total homocysteine (tHcy), folate and vitamin B12 in Alzheimer’s disease and mild cognitive impairment. Methods:Sixty-one Alzheimer’s disease (AD) patients, forty mild cognitive impairment (MCI) patients and forty-four normal controls were studied. The serum homocysteine (tHcy), folate, and vitamin B12 were measured and MMSE-K, GDS were evaluated for cognitive function. Results:Serum tHcy levels were significantly higher and folate levels were lower in patients with AD than in controls. And also serum folate levels were lower in MCI than in controls. Vitamin B12 did not have a significant difference among three groups. The serum homocysteine and folate levels shows significant correlation with MMSE-K. Conclusion:Elevated tHcy levels and low blood levels of folate were associated with AD. Serum folate were significantly lower levels in MCI than in controls. We suggested that serum tHcy, folate are useful risk markers for the development of cognitive dysfunction.

Abstract

Objectives:This study aimed to investigate the serum levels of total homocysteine (tHcy), folate and vitamin B12 in Alzheimer’s disease and mild cognitive impairment. Methods:Sixty-one Alzheimer’s disease (AD) patients, forty mild cognitive impairment (MCI) patients and forty-four normal controls were studied. The serum homocysteine (tHcy), folate, and vitamin B12 were measured and MMSE-K, GDS were evaluated for cognitive function. Results:Serum tHcy levels were significantly higher and folate levels were lower in patients with AD than in controls. And also serum folate levels were lower in MCI than in controls. Vitamin B12 did not have a significant difference among three groups. The serum homocysteine and folate levels shows significant correlation with MMSE-K. Conclusion:Elevated tHcy levels and low blood levels of folate were associated with AD. Serum folate were significantly lower levels in MCI than in controls. We suggested that serum tHcy, folate are useful risk markers for the development of cognitive dysfunction.

참고문헌 (40)

  1. Benjamin J, "Kaplan & Sadock’s synopsis of psychiatry.10th ed", pp.329~331 (2007), Lipponcott Williams & Wilkins
  2. Kral VA, "Senescent forgetfulness: benign and malignant", Can Med Assoc J, 86, pp.257~260 (1962)
  3. Crook T, "Age associated memory impairment: proposed diagnositc criteria and measures of clinical change-report of a National Institute of Mental Health Work Group", Dev Neuropsychol, 2, pp.261~276 (1986)
  4. Levy R, "Aging-associated cognitive decline", Int Psychogeriatr, 6, pp.63~68 (1994)
  5. Graham JE, "Prevalence and severity of cognitive impairment with and without dementia in an elderly population", Lancet, 349, pp.1793~1796 (1997)
  6. Reisberg B, "The Global Deterioration Scale for assessment of primary degenerative dementia", Am J Psychiatr, 139, pp.1136~1139 (1982)
  7. Flicker C, "Mild cognitive impairment in the elderly: predictors of dementia", Neurology, 41, pp.1006~1009 (1991)
  8. Morris JC, "The Clinical Dementia Rating (CDR): current version and scoring rules", Neurology, 43, pp.2412~2414 (1993)
  9. Morris JC, "Mild cognitive impairment represents earlystage Alzheimer’s disease", Arch Neurol, 58, pp.397~405 (2001)
  10. Petersen RC, "Mild cognitive impairment: An overview", CNS Spectr, 13, pp.45~53 (2008)
  11. Mitchell AJ, "Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies", Acta Psychiatr Scand, 119, pp.252~265 (2009)
  12. Vogel T, "Homocysteine, vitamin B12, folate and cognitive function: a systematic and critical review of the literature", Int J Clin Pract, 63, pp.1061~1067 (2009)
  13. Malaguarnera M, "Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease", Clin Chem Lab Med, 42, pp.1032~1035 (2004)
  14. Köseoglu E, "Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease", Clin Biochem, 40, pp.859~863 (2007)
  15. Quadri P, "Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia", Am J Clin Nutr, 80, pp.114~122 (2004)
  16. Ariğul S, "Vitamin B12,folate, homocysteine and dementia: are they really related?", Arch Geriatr, 40, pp.139~146 (2005)
  17. Ravaglia G, "Elevated plasma homocysteine levels in centernarians are not associated with cognitive impairment", Mech Ageing Dev, 121, pp.251~261 (2000)
  18. Durga J, "Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind,controlled trial", Lancet, 369, pp.208~216 (2007)
  19. Sommer BR, "Folic acid supplementation in dementia:a preliminary report", J Geriatr Psychiatry Neurol, 16, pp.156~159 (2003)
  20. McMahon JA, "A controlled trial of homocysteine lowering and cognitive performance", N Engl J Med, 354, pp.2764~2772 (2006)
  21. Hvas AM, "No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study", J Affect Disord, 81, pp.269~273 (2004)
  22. Lewerin C, "Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study", Am J Clin Nutr, 81, pp.1155~1162 (2005)
  23. Eussen SJ, "Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial", Am J Clin Nutr, 84, pp.361~370 (2006)
  24. American Psychiatric Association, "Diagnostic and statiscal manual of mental disorder", American Psychiatric Association, ~ (1994)
  25. McKhann G, "Clinical diagnosis of Alzheimer’s disease: report of NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease", Neurology, 34, pp.939~944 (1984)
  26. 권용철, "노인용 한국판 Mini-Mental State Examination (MMSE-K)의 표준화 연구-제1편: MMSE-K의 개발", 신경정신의학, 28, pp.125~135 (1989)
  27. Reisberg B, "The Global Deterioration Scale for assessment of primary degenerative dementia", Am J Psychiatry, 139, pp.1136~1139 (1982)
  28. Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiat, 23, pp.56~61 (1960)
  29. Clarke R, "Folate,vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease", Arch Neurol, 55, pp.1449~1455 (1998)
  30. Mcilroy SP, "Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland", Stroke, 33, pp.2351~2356 (2002)
  31. Lipton SA, "Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor", Proc Natl Acad Sci U S A, 94, pp.5923~5928 (1997)
  32. De La Torre JC, "Cerebral hypoperfusion, capillary degeneration and development of Alzheimer disease", Alzheimer Dis Assoc Disord, 14(Suppl 1), pp.S72~81 (2000)
  33. Hamel E, "Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer’s disease", Exp Physiol, 93, pp.116~120 (2008)
  34. Zhang CE, "Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain", Am J Pathol, 174, pp.1481~1491 (2009)
  35. Zhang CE, "Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus", Neurobiol Aging, 29, pp.1654~1665 (2008)
  36. Williams JH, "Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people", Age Ageing, 31, pp.440~444 (2002)
  37. Piazza F, "Increased tissue factor pathway inhibitor and homocysteine in Alzheimer’s disease", Neurobiol Aging, ~ (2010)
  38. Gallucci M, "Homocysteine in Alzheimer disease and vascular dementia", Arch Gerontol Geriatr, (Suppㅣ9), pp.195~200 (2004)
  39. Religa D, "Homocysteine, apolipoprotein E and methylenetetrahydrofolate reductase in Alzheimer’s disease and mild cognitive impairment", Dement Geriatr Cogn Disord, 16, pp.64~70 (2003)
  40. De Silva HA, "Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer’s disease", Exp Aging Res, 31, pp.345~354 (2005)

관련 논문AI추천

초기 알츠하이머병 환자의 호모시스테인 수준과 기억력의 관계강연욱, 박종식, 송인욱, 양영순, 정성우대한치매학회 · Dementia and Neurocognitive Disorders(대한치매학회지)2014 · 제13권 제2호One-Carbon Metabolism and Cognitive Impairment in a Korean Community Population김성완, 김재민, 신일선, 신희영, 양수진, 윤진상, Jung-Gon Kim, Sam-Yeon Lee, Woong-Jang Kim대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2007 · 제5권 제2호알츠하이머병, 혈관성 치매 및 경도인지장애와 호모시스테인 농도 증가의 연관성김건하, 김상범, 김희진, 윤지영, 이미선, 조선영, 최경규, 최병옥대한신경과학회 · 대한신경과학회지2006 · 제24권 제3호Normal-But-Low Serum Folate Levels and the Risks for Cognitive Impairment김신겸, 김태희, Bong Jo Kim, Dong Woo Lee, Dong Young Lee, Hyeon Jeong, Hyun-Ghang Jeong, Jae Young Park, Jeong Lan Kim, Jin Hyeong Jhoo, Ji Won Han, Ji-Yeong Seo, Jiyoon Shin, Jong Chul Youn, Jong Woo Hong, Joon Hyuk Park, Jung Jae Lee, Ju Ri Lee, Kayoung Kim, Ki Woong Kim, Kyoung Hwan Lee, Kyuhee Han, Kyung Phil Kwak, Seok Bum Lee, Seok Woo Moon, Seonjeong Byun, Seung-Ho Ryu, Seung Wan Suh, Soomin Jang, Taehyun Kim, Yoonseop So대한신경정신의학회 · PSYCHIATRY INVESTIGATION2019 · 제16권 제7호경도인지장애와 알츠하이머형 치매 환자에서 혈중Superoxide Dismutase 활성도와 Nitric oxide 및 Homocysteine 농도김영훈, 김지은, 박성우, 백준형, 신배섭, 유영선, 윤성욱, 이선정, 이정구, 전동욱, 정성수대한생물치료정신의학회 · 생물치료정신의학2007 · 제13권 제2호Plasma Total Homocysteine Levels are not Associated with Medial Temporal Lobe Atrophy, but with White Matter Changes in Alzheimer’s Disease김성래, 박신구, 윤대현, 최성혜, 편해욱, 하충건대한신경과학회 · Journal of Clinical Neurology2009 · 제5권 제2호

이 간행물의 다른 논문 (8건)